Cilo Cybin Holdings (JSE:CCC) Gross-Profit-to-Asset % : 0.00% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Cilo Cybin Holdings's annualized Gross Profit for the quarter that ended in Sep. 2024 was R0.00 Mil. Cilo Cybin Holdings's average Total Assets over the quarter that ended in Sep. 2024 was R60.68 Mil. Therefore, Cilo Cybin Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 0.00%.

Cilo Cybin Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for Cilo Cybin Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cilo Cybin Holdings Gross-Profit-to-Asset % Chart

Cilo Cybin Holdings Annual Data

Trend

Mar22

Mar23

Gross-Profit-to-Asset %

Cilo Cybin Holdings Semi-Annual Data
	Mar22	Mar23	Sep23	Sep24
Gross-Profit-to-Asset %	-	-	-	-

Competitive Comparison of Cilo Cybin Holdings's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Cilo Cybin Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cilo Cybin Holdings's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cilo Cybin Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Cilo Cybin Holdings's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Cilo Cybin Holdings Gross-Profit-to-Asset % Calculation

Cilo Cybin Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2023 )	/	( (Total Assets (A: Mar. 2022 )	+	Total Assets (A: Mar. 2023 ))	/ count )
	=	0	/	( (0.01	+	0.077)	/ 2 )
	=	0	/	0.0435
	=	0.00 %

Cilo Cybin Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2024 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	0	/	( (0	+	60.675)	/ 1 )
	=	0	/	60.675
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Cilo Cybin Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cilo Cybin Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » Gross-Profit-to-Asset %

Traded in Other Exchanges

N/A

Address

7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157

Website

https://www.cilocybin.com

Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines